|

unrelated umbilical cord blood Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • The First Affiliated Hospital with Nanjing Medical University1

Indications

  • Chronic Myelomonocytic Leukemia-21
  • Secondary Acute Myeloid Leukemia1
  • Myelodysplastic Syndromes1
  • Cancer1

Other1 trial

Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.